Behavioral Research and Treatment Center


The Behavioral Research and Treatment Center provides infrastructure support for state-of-the-science research in cancer prevention, cancer care and cancer survivorship.


The Behavioral Research and Treatment Center (BRTC), located on the second floor of the Dan L Duncan Building at MD Anderson Cancer Center is designed to support population-based research studies in behavioral science, health disparities, and integrative medicine. The studies and clinical trials conducted in the center are specifically related to tobacco cessation, exercise during and after cancer treatment, and behaviors and emotions associated with cancer and cancer-forming habits. 

The BRTC is the central headquarters to as many as 45 clinical trials and research studies including the Tobacco Treatment Program, MD Anderson’s institution-wide tobacco cessation and relapse prevention program.  

The center provides research investigators the tools and space needed to conduct clinical trials and research benefiting smokers, non-smokers, cancer survivors and cancer patients. The center has an array of trials and studies available to the community as well as MD Anderson patients.

What is a clinical trial or study?

Often referred to as clinical research, a clinical trial or research study is medical research that involves people who participate in a carefully executed investigation conducted in a laboratory or patient-care setting where new therapies and procedures are tested. The goal is to discover better ways to prevent, treat, diagnose and understand disease.

For information about a specific study or clinical trial conducted in the BRTC, please call the number associated with study.

For additional information about the BRTC, please call Cheryl Dayton-Shotts at 713-792-4653 or the BRTC main line at 713-563-5960.